BioCryst Pharmaceuticals Stock Sees RS Rating Rise To 84

The Relative Strength (RS) Rating for BioCryst Pharmaceuticals (BCRX) stock climbed into a new percentile Friday, with a rise from 64 to 84. X When looking for the best stocks to buy and watch, one fa...

BioCryst Stock at $21 a Share? This Analyst Thinks It’s Possible

The week began in the best possible way for BioCryst (BCRX) investors. Shares saw out Monday’s session with 28% of gains attached to the ticker, as the market applauded preliminary fourth-quarter reve...